Device Trial Radar · NCT05538754
Post-Market Evaluation of the EVO ICL
Last checked: Nov 20, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
205
Actual
Start
Sep 23, 2022
Primary completion
Sep 21, 2023
Study completion Oct 4, 2023
Sponsor
- Lead sponsor
- Staar Surgical CompanyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 14, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to assess the rate of early intraocular pressure (IOP) increases following implantation of EVO/EVO+ Implantable Collamer Lens (ICL).
Conditions
- Myopia
- Myopic Astigmatism
Interventions
EVO ICLDevice
The EVO ICL is intended to be implanted within the posterior chamber, directly behind the iris, and in front of the anterior capsule of the human crystalline lens.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Elevated Intraocular Pressure (IOP) in Primary Eyes ≥ 30 mmHgTime frame: 1-6 hours postoperatively
- Elevated Intraocular Pressure (IOP) in Primary Eyes ≥ 40 mmHGTime frame: 1-6 hours postoperatively
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Aloha Laser Vision, LLC
Honolulu, Hawaii
Durrie Vision
Overland Park, Kansas
Kugler Vision, PC
Omaha, Nebraska
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.